This study looks at how well and how safely the drug pradefovir mesylate works for people with chronic hepatitis B. About 400 adults aged 18 to 65 with active hepatitis B will take the drug and be followed over time. The main goal is to see if the drug can lower the virus to unde…
Sponsor: Juan Li • Aim: Disease control
Last updated May 06, 2026 16:13 UTC